Advertisement
Screener

DAVITA INC. (DVA) Proceeds from Sales of Business, Affiliate and Productive Assets

DAVITA INC. Proceeds from Sales of Business, Affiliate and Productive Assets

DAVITA INC. (DVA) reported Proceeds from Sales of Business, Affiliate and Productive Assets of $4.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Investing Activities

us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets · last filed 2026-08-04

  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for the quarter ending 2026-06-30 was $671.00K, a 94.28% decline year-over-year.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for the quarter ending 2026-03-31 was $3.72M, a 65.14% decline year-over-year.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for the quarter ending 2025-12-31 was $1.84M, a 76.83% decline year-over-year.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for the quarter ending 2025-09-30 was $9.94M, a 92.65% increase year-over-year.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for fiscal 2025 was $34.17M, a 32.14% increase from fiscal 2024.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for fiscal 2024 was $25.86M, a 15.51% decline from fiscal 2023.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for fiscal 2023 was $30.61M, a 73.97% decline from fiscal 2022.
  • DAVITA INC. proceeds from sales of business, affiliate and productive assets for fiscal 2022 was $117.58M, a 91.30% increase from fiscal 2021.
Period endProceeds from Sales of Business, Affiliate and Productive Assets 3 monthProceeds from Sales of Business, Affiliate and Productive Assets 6 monthProceeds from Sales of Business, Affiliate and Productive Assets 9 monthProceeds from Sales of Business, Affiliate and Productive Assets 12 month
2026-06-30$671.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$4.39M
10-Q · filed 2026-08-04
$6.23M
derived: sum of 3 quarters · filed 2026-08-04
$16.16M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31$3.72M
10-Q · filed 2026-05-05
$5.56M
derived: sum of 2 quarters · filed 2026-05-05
$15.49M
derived: sum of 3 quarters · filed 2026-05-05
$27.22M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$11.77M
derived: sum of 2 quarters · filed 2026-02-11
$23.50M
derived: sum of 3 quarters · filed 2026-08-04
$34.17M
10-K · filed 2026-02-11
2025-09-30$9.94M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$21.66M
derived: sum of 2 quarters · filed 2026-08-04
$32.34M
10-Q · filed 2025-10-29
$40.26M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30$11.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
$22.40M
10-Q · filed 2026-08-04
$30.32M
derived: sum of 3 quarters · filed 2026-08-04
$35.48M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31$10.67M
10-Q · filed 2026-05-05
$18.60M
derived: sum of 2 quarters · filed 2026-05-05
$23.76M
derived: sum of 3 quarters · filed 2026-05-05
$29.50M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$7.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$13.08M
derived: sum of 2 quarters · filed 2026-02-11
$18.82M
derived: sum of 3 quarters · filed 2026-02-11
$25.86M
10-K · filed 2026-02-11
2024-09-30$5.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29
$10.90M
derived: sum of 2 quarters · filed 2025-10-29
$17.94M
10-Q · filed 2025-10-29
$23.64M
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$5.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$12.78M
10-Q · filed 2025-08-05
$18.48M
derived: sum of 3 quarters · filed 2026-02-11
$22.19M
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$7.04M
10-Q · filed 2025-05-12
$12.74M
derived: sum of 2 quarters · filed 2026-02-11
$16.45M
derived: sum of 3 quarters · filed 2026-02-11
$24.18M
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$5.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$9.41M
derived: sum of 2 quarters · filed 2026-02-11
$17.14M
derived: sum of 3 quarters · filed 2026-02-11
$30.61M
10-K · filed 2026-02-11
2023-09-30$3.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$11.43M
derived: sum of 2 quarters · filed 2024-10-29
$24.91M
10-Q · filed 2024-10-29
$26.40M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$7.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$21.20M
10-Q · filed 2024-08-06
$22.69M
derived: sum of 3 quarters · filed 2025-02-13
$23.95M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$13.47M
10-Q · filed 2024-05-02
$14.97M
derived: sum of 2 quarters · filed 2025-02-13
$16.23M
derived: sum of 3 quarters · filed 2025-02-13
$119.70M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$1.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$2.75M
derived: sum of 2 quarters · filed 2025-02-13
$106.23M
derived: sum of 3 quarters · filed 2025-02-13
$117.58M
10-K · filed 2025-02-13
2022-09-30$1.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$104.73M
derived: sum of 2 quarters · filed 2023-11-07
$116.09M
10-Q · filed 2023-11-07
$130.97M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$103.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$114.83M
10-Q · filed 2023-08-03
$129.72M
derived: sum of 3 quarters · filed 2024-02-14
$146.52M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$11.35M
10-Q · filed 2023-05-08
$26.24M
derived: sum of 2 quarters · filed 2024-02-14
$43.04M
derived: sum of 3 quarters · filed 2024-02-14
$56.48M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$14.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$31.69M
derived: sum of 2 quarters · filed 2024-02-14
$45.13M
derived: sum of 3 quarters · filed 2024-02-14
$61.46M
10-K · filed 2024-02-14
2021-09-30$16.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31
$30.24M
derived: sum of 2 quarters · filed 2022-10-31
$46.58M
10-Q · filed 2022-10-31
$13.38M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$13.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01
$29.77M
10-Q · filed 2022-08-01
-$3.43M
derived: sum of 3 quarters · filed 2023-02-22
$9.30M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$16.34M
10-Q · filed 2022-05-05
-$16.86M
derived: sum of 2 quarters · filed 2023-02-22
-$4.14M
derived: sum of 3 quarters · filed 2023-02-22
$34.96M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31-$33.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
-$20.48M
derived: sum of 2 quarters · filed 2023-02-22
$18.62M
derived: sum of 3 quarters · filed 2023-02-22
$50.14M
10-K · filed 2023-02-22
2020-09-30$12.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
$51.82M
derived: sum of 2 quarters · filed 2021-10-28
$83.34M
10-Q · filed 2021-10-28
$97.11M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$39.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$70.61M
10-Q · filed 2021-08-03
$84.39M
derived: sum of 3 quarters · filed 2022-02-11
$96.63M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$31.52M
10-Q · filed 2021-04-29
$45.29M
derived: sum of 2 quarters · filed 2022-02-11
$57.53M
derived: sum of 3 quarters · filed 2022-02-11
$3.90B
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31$13.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$26.01M
derived: sum of 2 quarters · filed 2022-02-11
$3.86B
derived: sum of 3 quarters · filed 2022-02-11
$3.88B
10-K · filed 2022-02-11
2019-09-30$12.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$3.85B
derived: sum of 2 quarters · filed 2020-10-29
$3.86B
10-Q · filed 2020-10-29
$3.88B
derived: sum of 4 quarters · filed 2021-02-12
2019-06-30$3.84B
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$3.85B
10-Q · filed 2020-07-30
$3.87B
derived: sum of 3 quarters · filed 2021-02-12
$3.89B
derived: sum of 4 quarters · filed 2021-02-12
2019-03-31$13.90M
10-Q · filed 2020-05-05
$28.84M
derived: sum of 2 quarters · filed 2021-02-12
$47.87M
derived: sum of 3 quarters · filed 2021-02-12
$145.57M
derived: sum of 4 quarters · filed 2021-02-12
2018-12-31$14.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12
$33.96M
derived: sum of 2 quarters · filed 2021-02-12
$131.67M
derived: sum of 3 quarters · filed 2021-02-12
$150.21M
10-K · filed 2021-02-12
2018-09-30$19.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$116.73M
derived: sum of 2 quarters · filed 2019-11-07
$135.27M
10-Q · filed 2019-11-07
$135.07M
derived: sum of 4 quarters · filed 2020-02-21
2018-06-30$97.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$116.24M
10-Q · filed 2019-08-02
$116.05M
derived: sum of 3 quarters · filed 2020-02-21
$138.34M
derived: sum of 4 quarters · filed 2020-02-21
2018-03-31$18.54M
10-Q · filed 2019-05-07
$18.34M
derived: sum of 2 quarters · filed 2020-02-21
$40.63M
derived: sum of 3 quarters · filed 2020-02-21
$64.26M
derived: sum of 4 quarters · filed 2020-02-21
2017-12-31-$193.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21
$22.10M
derived: sum of 2 quarters · filed 2020-02-21
$45.72M
derived: sum of 3 quarters · filed 2020-02-21
$92.34M
10-K · filed 2020-02-21
2017-09-30$22.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$45.92M
derived: sum of 2 quarters · filed 2018-11-07
$92.53M
10-Q · filed 2018-11-07
$138.26M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$23.62M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
$70.24M
10-Q · filed 2018-08-01
$115.97M
derived: sum of 3 quarters · filed 2019-02-22
$117.57M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$46.61M
10-Q · filed 2018-05-03
$92.35M
derived: sum of 2 quarters · filed 2019-02-22
$93.94M
derived: sum of 3 quarters · filed 2019-02-22
$106.68M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$45.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$47.33M
derived: sum of 2 quarters · filed 2019-02-22
$60.07M
derived: sum of 3 quarters · filed 2019-02-22
$64.72M
10-K · filed 2019-02-22
2016-09-30$1.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$14.33M
derived: sum of 2 quarters · filed 2017-11-07
$18.99M
10-Q · filed 2017-11-07
$31.84M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$12.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01
$17.39M
10-Q · filed 2017-08-01
$30.24M
derived: sum of 3 quarters · filed 2018-02-23
$33.69M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31$4.66M
10-Q · filed 2017-05-02
$17.51M
derived: sum of 2 quarters · filed 2018-02-23
$20.96M
derived: sum of 3 quarters · filed 2018-02-23
$21.81M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$12.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$16.30M
derived: sum of 2 quarters · filed 2018-02-23
$17.15M
derived: sum of 3 quarters · filed 2018-02-23
$19.71M
10-K · filed 2018-02-23
2015-09-30$3.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$4.30M
derived: sum of 2 quarters · filed 2016-11-02
$6.87M
10-Q · filed 2016-11-02
$12.04M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$850.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$3.42M
10-Q · filed 2016-08-08
$8.59M
derived: sum of 3 quarters · filed 2017-02-24
$11.99M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$2.56M
10-Q · filed 2016-05-04
$7.74M
derived: sum of 2 quarters · filed 2017-02-24
$11.14M
derived: sum of 3 quarters · filed 2017-02-24
2014-12-31$5.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$8.58M
derived: sum of 2 quarters · filed 2017-02-24
$8.79M
10-K · filed 2017-02-24
2014-09-30$3.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$3.62M
10-Q · filed 2015-11-05
2014-06-30$215.00K
10-Q · filed 2015-08-05
2013-12-31$62.26M
10-K · filed 2016-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sotera Health Co (SHC)United States$5.271B30.96
Progyny, Inc. (PGNY)United States$1.994B28.37
agilon health, inc. (AGL)United States$1.272B-7.76
VIEMED HEALTHCARE, INC. (VMD)United States$0.336B29.92
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43